Vident Investment Advisory, LLC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 176 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 4.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
Vident Investment Advisory, LLC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$499,992
-23.7%
101,213
-2.8%
0.02%
-36.0%
Q4 2022$654,953
-6.7%
104,126
+59.9%
0.02%
+8.7%
Q3 2022$702,000
-14.5%
65,131
-9.6%
0.02%
-8.0%
Q2 2022$821,000
+16.3%
72,016
-7.0%
0.02%
+38.9%
Q1 2022$706,000
-26.7%
77,457
+20.0%
0.02%
-28.0%
Q4 2021$963,000
-33.8%
64,547
+14.1%
0.02%
-43.2%
Q3 2021$1,454,000
-8.0%
56,579
-6.7%
0.04%
-8.3%
Q2 2021$1,581,000
-24.8%
60,621
+1.8%
0.05%
-32.4%
Q1 2021$2,103,000
+39.9%
59,5640.0%0.07%
+16.4%
Q4 2020$1,503,000
+31.4%
59,564
+96.3%
0.06%
+7.0%
Q3 2020$1,144,000
-26.6%
30,336
-16.7%
0.06%
-30.5%
Q2 2020$1,559,000
+46.5%
36,406
-33.5%
0.08%
+17.1%
Q1 2020$1,064,000
-27.0%
54,748
-2.4%
0.07%
-22.2%
Q4 2019$1,457,000
+1.3%
56,070
+6.1%
0.09%
-28.6%
Q3 2019$1,439,000
-1.4%
52,823
-2.8%
0.13%
+7.7%
Q2 2019$1,459,000
-14.9%
54,332
-8.4%
0.12%
+27.2%
Q1 2019$1,715,000
+5.0%
59,330
-2.2%
0.09%0.0%
Q4 2018$1,634,00060,6820.09%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$5,700,1778.82%
Wildcat Capital Management, LLC 1,920,787$6,088,8952.44%
TPG GP A, LLC 18,716,306$59,330,6901.02%
EcoR1 Capital, LLC 4,488,200$14,227,5940.48%
CROSSPOINT FINANCIAL, LLC 12,000$38,0400.40%
Coastal Bridge Advisors, LLC 406,847$1,289,7050.35%
CAXTON ASSOCIATES LP 480,104$1,521,9300.21%
Woodline Partners LP 5,313,915$16,845,1110.20%
Rhenman & Partners Asset Management AB 300,000$951,0000.10%
Navalign, LLC 75,365$238,9070.09%
View complete list of ALLOGENE THERAPEUTICS INC shareholders